ProclaRx Overview

  • Founded
  • 2014
  • Status
  • Out of Business
  • Employees
  • 3
  • Latest Deal Type
  • Out of Business

ProclaRx General Information


Provider of therapeutics designed to develop and commercialize anti-bacterial biofilm IP technology. The company's therapeutics are mainly for biofilm-associated chronic and recurrent bacterial infections that offers bacterial biofilm disruption mechanism, enabling physicians to optimize commercialization pathways while keeping costs low.

Contact Information

Formerly Known As
Lattice Biotech
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Suite 212
  • 340 West State Street
  • Athens, OH 45701
  • United States
+1 (614) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

ProclaRx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 01-Dec-2018 00.000 Completed Out of Business
2. Early Stage VC 27-Feb-2017 00000 00.000 Completed Generating Revenue
1. Angel (individual) 12-Jan-2016 $5.5M $5.5M Completed Startup
To view ProclaRx’s complete valuation and funding history, request access »

ProclaRx Comparisons

HQ Location
Total Raised
Post Valuation
Last Financing Details
Provider of therapeutics designed to develop and commercialize anti-bacterial biofilm IP technology. The company's thera
Athens, OH
3 As of 2016
00000000 00 00.000


llum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa
0000 000000000
Vienna, Austria
0000000000 00.000


magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex
South San Francisco, CA
00 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ProclaRx Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Apeptico Forschung und Entwicklung Venture Capital-Backed Vienna, Austria 00.000 0000000000 00.000
00000000 Formerly VC-backed South San Francisco, CA 00 00000 0000000000.
000000 00000000000 Private Equity-Backed Copenhagen, Denmark 0000 000000000000
000000 00000000000 Formerly VC-backed Los Gatos, CA 00 000.00 000000000 000.00
000000 000000 Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
You’re viewing 5 of 12 competitors. Get the full list »

ProclaRx Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial